Paulson & Co.
In its 13F for Q1 2026 (holdings as of March 31, 2026, filed May 15, 2026), John Paulson's Paulson & Co. reported 9 stock positions worth $3.1 billion. Its top holding was Perpetua Resources (PPTA) at 29.2% of the portfolio, followed by Madrigal Pharmaceuticals (MDGL, 23.4%) and Acadian Asset Management (AAMI, 13.5%). Compared with Q4 2025, it opened 1 new position, sold out of 1, added to 2 and reduced 1. The biggest buy was Intl Tower Hill Mines (THM, shares +42%) and the biggest sale Madrigal Pharmaceuticals (MDGL, shares −18%).
- Most Recent 13F
- Q2 2026
- Notable People
- John Paulson
- Location
- JERSEY CITY, NJ
- CIK
- 0001035674
- Portfolio Value
- $3.1B (Q1 2026)
- SEC Filing
- 0001013594-26-000611 ↗ filed May 15, 2026
Holdings Value
Holdings 9 stocks · $3.1B
| PPTA Perpetua Resources Corp. | 29.23% | 32,347,299 | $909.6M | No change |
| MDGL Madrigal Pharmaceuticals Inc. | 23.42% | 1,392,188 | $728.8M | Reduce -18.5% |
| AAMI Acadian Asset Management Inc. | 13.54% | 7,743,282 | $421.4M | No change |
| BHC Bausch Health Cos Inc. | 12.71% | 73,255,869 | $395.6M | No change |
| NG Novagold Resources Inc. | 7.86% | 27,238,061 | $244.6M | No change |
| THM Intl Tower Hill Mines Ltd. filed as INTERNATIONAL TOWER HILL MIN | 7.36% | 99,573,038 | $229.0M | Add +41.8% |
| AEM Agnico Eagle Mines Ltd. | 5.11% | 783,561 | $159.0M | No change |
| THRY Thryv Holdings Inc. | 0.74% | 8,443,835 | $23.1M | Add +94.2% |
| FOLD Amicus Therapeutics Inc. | 0.02% | 32,400 | $469K | New |
Portfolio Sells Q4 2025 → Q1 2026
Portfolio Buys Q4 2025 → Q1 2026
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $2.6B | MDGL, PPTA, AAMI, BHC, THM |
| Q1 2026 | 9 | $3.1B | PPTA, MDGL, AAMI, BHC, NG |
| Q4 2025 | 9 | $3.3B | MDGL, PPTA, BHC, AAMI, NG |
| Q3 2025 | 10 | $3.0B | MDGL, PPTA, BHC, AAMI, NG |
| Q2 2025 | 15 | $2.0B | MDGL, PPTA, AAMI, BHC, NG |
| Q1 2025 | 14 | $1.7B | MDGL, PPTA, AAMI, BHC, AEM |
| Q4 2024 | 13 | $1.7B | MDGL, PPTA, AAMI, BHC, NG |
| Q3 2024 | 15 | $1.4B | MDGL, PPTA, AAMI, BHC, NG |
| Q2 2024 | 16 | $1.4B | MDGL, AAMI, BHC, PPTA, NG |
| Q1 2024 | 18 | $1.4B | MDGL, BHC, AAMI, PPTA, NG |